Time filter

Source Type

Degryse S.,Center for the Biology of the Disease | Degryse S.,Catholic University of Leuven | Cools J.,Center for the Biology of the Disease | Cools J.,Catholic University of Leuven
Journal of Hematology and Oncology | Year: 2015

Recent studies of acute lymphoblastic leukemia have identified activating mutations in components of the interleukin-7 receptor complex (IL7R, JAK1, and JAK3). It will be of interest to investigate both JAK1 and JAK3 kinase inhibitors as targeted agents for these leukemias. © 2015 Degryse and Cools. Source

Discover hidden collaborations